Related articles
Access to multi-indication medicines in underserved autoimmune diseases: Are there better approaches to supporting sustainable access?
Multi-indication Medicines15/12/2025
Expanding patient access to multi-indication medicines through innovative agreements
Multi-indication Medicines28/10/2025
Pricing and reimbursement of multiple indication medicines: Can a balance be found between different stakeholder perspectives to optimise value and access for patients, while ensuring sustainable and affordable innovation?
Multi-indication Medicines17/11/2024